MANAGEMENT AND EFFECTIVENESS OF NABPACLITAXEL IN METASTASIC PANCREATIC ADENOCARCINOMA
5PSQ-060
AN ACUTE AND SEVERE EVENT IN A PATIENT TREATED WITH RAMUCIRUMAB
5PSQ-057
DEVELOPMENT OF AN ANALYSIS METHOD TO ASSESS THE OCCUPATIONAL RISK DEALING WITH THERAPEUTIC MONOCLONAL ANTIBODIES USING LIQUID CHROMATOGRAPHY AND HIGH-RESOLUTION MASS SPECTROMETRY (LC-HRMS)
5PSQ-050
NEUROPSYCHIATRIC ADVERSE EFFECTS ON DOLUTEGRAVIR: EXPERIENCE IN A THIRD-LEVEL HOSPITAL
5PSQ-043
NEBULISED VORICONAZOLE IN LUNG TRANSPLANT RECIPIENTS: ANALYSIS OF USE, EFFICACY AND TOLERABILITY
5PSQ-041
INCIDENTS DUE TO THE USE OF ANTIBIOTICS DETECTED IN THE PAEDIATRIC EMERGENCY SERVICE OF A THIRD-LEVEL HOSPITAL
5PSQ-040
ANTIBIOTIC USE IN A TERTIARY CARE HOSPITAL
5PSQ-037
EVOLUTION OF THE ANTIMICROBIAL STEWARDSHIP PROGRAMME QUALITY INDICATORS IN A THIRDLEVEL HOSPITAL
5PSQ-036
EVALUATION OF AN ANTIMICROBIAL STEWARDSHIP INTERVENTION IN A GENERAL HOSPITAL
5PSQ-035
RELEVANCE OF FLUOROQUINOLONE PRESCRIPTION IN HOSPITAL
5PSQ-027
EARLY REAL-WORLD EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH PSORIASIS
5PSQ-023
THE IMPORTANCE OF THE EVALUATION OF AMIODARONE’S PLASMATIC CONCENTRATION IN PATIENTS WITH ATRIAL FIBRILLATION
5PSQ-019
AN ORGANISATIONAL APPROACH TO IMPROVE THE SAFETY OF INTRAVENOUS POTASSIUM CHLORIDE REPLACEMENT: DATA FROM A TERTIARY CARE HOSPITAL
5PSQ-016
SAFE USE OF ANTIPLATELET MEDICATION: APPROACHING THE OPTIMAL DOSE OF ASPIRIN BY PHARMACEUTICAL INTERVENTION
5PSQ-009
ADEQUACY OF USE AND EFFECTIVENESS OF GLP-1 RECEPTOR AGONISTS IN REAL CLINICAL PRACTICE
